AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen

Uloženo v:
Podrobná bibliografie
Název: AAMP and MTSS1 Are Novel Negative Regulators of Endothelial Barrier Function Identified in a Proteomics Screen
Autoři: Fabienne Podieh, Max C. Overboom, Jaco C. Knol, Sander R. Piersma, Richard Goeij-de Haas, Thang V. Pham, Connie R. Jimenez, Peter L. Hordijk
Zdroj: Cells
Cells, Vol 13, Iss 19, p 1609 (2024)
Informace o vydavateli: MDPI AG, 2024.
Rok vydání: 2024
Témata: Proteomics, Microfilament Proteins/metabolism, Endothelial Cells/metabolism, Article, Cortactin/metabolism, Capillary Permeability, rhoA GTP-Binding Protein/metabolism, ubiquitin, Rho GTPases, Human Umbilical Vein Endothelial Cells, Humans, rhoB GTP-Binding Protein, Human Umbilical Vein Endothelial Cells/metabolism, QH573-671, protein turnover, Microfilament Proteins, rhoB GTP-Binding Protein/metabolism, Ubiquitination, Endothelial Cells, endothelial cells, Actins, Actins/metabolism, Proteomics/methods, Cytology, rhoA GTP-Binding Protein, Cortactin, monolayer integrity
Popis: Cell–cell adhesion in endothelial monolayers is tightly controlled and crucial for vascular integrity. Recently, we reported on the importance of fast protein turnover for maintenance of endothelial barrier function. Specifically, continuous ubiquitination and degradation of the Rho GTPase RhoB is crucial to preserve quiescent endothelial integrity. Here, we sought to identify other barrier regulators, which are characterized by a short half-life, using a proteomics approach. Following short-term inhibition of ubiquitination with E1 ligase inhibitor MLN7243 or Cullin E3 ligase inhibitor MLN4924 in primary human endothelial cells, we identified sixty significantly differentially expressed proteins. Intriguingly, our data showed that AAMP and MTSS1 are novel negative regulators of endothelial barrier function and that their turnover is tightly controlled by ubiquitination. Mechanistically, AAMP regulates the stability and activity of RhoA and RhoB, and colocalizes with F-actin and cortactin at membrane ruffles, possibly regulating F-actin dynamics. Taken together, these findings demonstrate the critical role of protein turnover of specific proteins in the regulation of endothelial barrier function, contributing to our options to target dysregulation of vascular permeability.
Druh dokumentu: Article
Other literature type
Jazyk: English
ISSN: 2073-4409
DOI: 10.3390/cells13191609
Přístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39404373
https://doaj.org/article/80f2bfadc11645b6aa1d1963fc5fbf74
https://pure.amsterdamumc.nl/en/publications/ef5658a1-5c24-4f11-89af-1c53acfbcaf1
https://doi.org/10.3390/cells13191609
Rights: CC BY
Přístupové číslo: edsair.doi.dedup.....cd7da2c1bc626bd6875a8e178d1f1fff
Databáze: OpenAIRE
Popis
Abstrakt:Cell–cell adhesion in endothelial monolayers is tightly controlled and crucial for vascular integrity. Recently, we reported on the importance of fast protein turnover for maintenance of endothelial barrier function. Specifically, continuous ubiquitination and degradation of the Rho GTPase RhoB is crucial to preserve quiescent endothelial integrity. Here, we sought to identify other barrier regulators, which are characterized by a short half-life, using a proteomics approach. Following short-term inhibition of ubiquitination with E1 ligase inhibitor MLN7243 or Cullin E3 ligase inhibitor MLN4924 in primary human endothelial cells, we identified sixty significantly differentially expressed proteins. Intriguingly, our data showed that AAMP and MTSS1 are novel negative regulators of endothelial barrier function and that their turnover is tightly controlled by ubiquitination. Mechanistically, AAMP regulates the stability and activity of RhoA and RhoB, and colocalizes with F-actin and cortactin at membrane ruffles, possibly regulating F-actin dynamics. Taken together, these findings demonstrate the critical role of protein turnover of specific proteins in the regulation of endothelial barrier function, contributing to our options to target dysregulation of vascular permeability.
ISSN:20734409
DOI:10.3390/cells13191609